Medtronic launches clinical trial of AdaptivCRT physiologic pacing algorithm

Medtronic announced an international clinical trial comparing standard cardiac resynchronization therapy against CRT with the AdaptivCRT physiologic pacing algorithm that makes automatic adjustments to the therapy.

ReShape targets U.S. approval as EU study shows major weight loss

ReShape Medical revealed the first postapproval data from the EU for its nonsurgical, balloon-based weight-loss system: 42% of excess weight loss on average with a variance of 23%. But the company cautions that because of the different way the trials are designed, it won't have similar results when it releases pivotal U.S. trial data in November.

White House spotlights need for electrical implants to treat inflammatory and neurological diseases

President Obama highlighted a $78.9 million BRAIN Initiative project to improve service members' and veterans' health through the development of nano-scale electrical implants to modulate nerve signaling and record health biomarkers.

J&J's DePuy Synthes unit slapped with FDA Class I recall for jaw-stabilizing device

Johnson & Johnson's DePuy Synthes unit is facing regulators' ire as the FDA slapped the company's recall of its jaw-stabilizing device with a Class I label, its most serious designation.

Biomarker could improve early rheumatoid arthritis diagnosis

A novel biomarker could make it easier for physicians to diagnose rheumatoid arthritis early, thereby improving patients' prospects. The best results come when conventional antibody testing is combined with the new biomarker.

Medtronic expands hospital services push with $350M acquisition

Medtronic  wants to be known for manufacturing high-quality devices and providing related services as well. To that end, the company today announced the acquisition of privately held Italian company NGC Medical S.p.A.

Med tech IPOs for NeuroSigma, ReWalk ready for fall

Epilepsy devicemaker NeuroSigma filed to raise up to $50 million in an IPO, while ReWalk--whose mobile exoskeletons were recently approved by the FDA--set IPO terms to raise $50 million.

Xprize seeks Star Trek's tricorder in $10M mobile diagnostics competition

A competition three-and-a-half years in the making is nearing a finish to find the real-life diagnostic technologies that are closest to replicating the omnipresent tricorder health diagnostic device featured in the science-fiction television drama Star Trek.

In India, surgeons use 3-D printed skull for practice

Plastic surgeons in India were able to convert CT scans of a three-year-old girl suffering with craniosynostosis into a physical replica using a 3-D printer. The realistic, life-size model was then used in practice runs of the surgery.

Study finds robotic prostate removal surgery results in faster recovery times

A study of robotic laparoscopic radical prostatectomy found that though it is more expensive than traditional prostate removal surgery and technically more demanding, it is also associated with a quicker recovery of continence and shorter operating time.

Mobile medical app provider reels in $25M to expand innovative monitoring system

Mobile medical app provider AirStrip reeled in $25 million in strategic capital to beef up its product offerings and develop its innovative health monitoring system for smartphones.

Philips Lifeline adds emergency response app to its service

Philips is working to get its healthcare business back on track after a recent dismal quarter for the business and a management re-shuffle for it. Its latest missive is an emergency assistance app from the Philips Lifeline unit that gives seniors 24-hour access to emergency assistance.

Boston Sci gets bad news on four of 23,000+ vaginal mesh lawsuits

Boston Scientific faces more than 23,000 lawsuits over its Pinnacle transvaginal mesh device. Last week it failed to remove four cases from a consolidated multidistrict litigation suit in the U.S. District Court for Western Virginia.

Researchers develop implant/app combo to monitor glaucoma in aging eyes

Researchers are developing an implantable sensor for glaucoma that allows intraocular pressure to be read by a smartphone camera. Diagnosis and monitoring now relies on a trip to the ophthalmologist and a reading of intraocular pressure that can vary widely. The implant/smartphone combination is expected to allow at-home monitoring and a series of readings that could improve diagnosis and monitoring of glaucoma patients.

Cardiologists overstate benefits of stenting, patients fail to recall their precautions

When the heart is at risk, patients are eager to listen to their doctor's recommendations. But three studies have found that many cardiologists oversell the benefits of percutaneous coronary interventions involving stenting, and patients often fail to remember the doctor's precautions about the procedure.

Medtronic adds to neuromodulation biz with $200M Sapiens acquisition

Medtronic today announced the $200 million acquisition of the Netherlands' Sapiens Steering Brain Stimulation to bulk up its neuromodulation offerings.

FDA approves next-generation Medtronic pacemaker

Medtronic snagged FDA approval for its next-generation cardiac resynchronization therapy (CRT) pacemaker in patients with heart failure, expanding its cardiovascular portfolio and advancing its proprietary technology for heart rhythm therapy.

Scientists develop computer-based quality-control program for cellular engineering

Scientists from three Boston institutions have created CellNet, a computer algorithm to assist scientists in their efforts to engineer specialized cells.

Device to make doctors wash their hands debuts

Biovigil Hygiene Technologies has developed a device that detects when a medical professional enters a patient's room and subsequently issues an alert if the doctor did not wash their hands after patient care.

Endo reported to be selling its AMS medical device unit

Endo Health Solutions is shopping its medical device unit American Medical Systems. The Minnetonka, MN-based company was recently in the news for settling many of its vaginal mesh-related lawsuits, and has caught the attention of private-equity firms and other health care companies.